Review of Medicare Payments for NovoSeven Coagulation Factor VIIA to Indiana Hemophilia and Thrombosis Center, Inc. From January 1, 2008, Through December 31, 2009
The Indiana Hemophilia and Thrombosis Center, Inc. (the Center) received net Medicare overpayments for NovoSeven dispensations of $435,000 for the period January 1, 2008, through December 31, 2009.
Download the complete report
Adobe® Acrobat® is required to read PDF files.
Copies can also be obtained by contacting the Office of Public Affairs at 202-619-1343.
Let's start by choosing a topic
Priority recommendations summarized.
FY 2017 Work Plan
OIG projects planned for 2017.
Significant OIG activities in 6-month increments.